Streetbeat News

Products Services

VYNE

VYNE Therapeutics has initiated a Phase 1b trial for VYN202, a novel oral BET inhibitor, in patients with moderate-to-severe plaque psoriasis. The trial will assess safety, pharmacokinetics, and preliminary efficacy over 12 weeks, with results expected by the end of 2025.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

ICAD

iCAD, Inc. will present five AI-powered research presentations at the European Congress of Radiology 2025, focusing on advancements in breast cancer detection, risk evaluation, and breast arterial calcification assessment.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

DXR

Daxor Corporation announced new studies from Duke and Yale on blood volume analysis, presented at the THT 2025 conference. The studies highlight limitations in pulmonary artery pressure monitoring and introduce new insights on diuretics.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

MIST

Milestone Pharmaceuticals has received a Notice of Allowance from the USPTO for a new patent on its lead product, etripamil nasal spray, aimed at treating PSVT.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

ACXP

Acurx Pharmaceuticals has been granted a new patent by the Japanese Patent Office for its DNA Polymerase IIIC inhibitors, which are part of its antibiotic development efforts.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

RSSS

Research Solutions (NASDAQ: RSSS) has launched a new AI feature called Tables in Scite Assistant, enhancing the ability to extract and analyze data from scientific literature.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

LGIH

LGI Homes has announced the grand opening of a new section at Homestead Estates in Elgin, Texas, offering affordable and upgraded homes starting in the $290s.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

NKGN

NKGen Biotech has appointed Dr. Anita Fletcher as the National Principal Investigator for its Phase 2a trial of troculeucel, an NK cell therapy for moderate Alzheimer's disease. AdventHealth Orlando will be the first East Coast site for patient enrollment.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

ARDX

Ardelyx, Inc. (Nasdaq: ARDX) will present at the TD Cowen 45th Annual Health Care Conference on March 3, 2025. This event could provide insights into the company's future plans and developments.

Portfolio Pulse from

February 19, 2025 | 1:15 pm

TWOSF

T2 Metals Corp. has started its 2025 winter drill program at the Sherridon copper-gold project in Manitoba, focusing on the Bob Lake deposit and new regional targets.

Portfolio Pulse from

February 19, 2025 | 1:15 pm